A Study in Healthy Men to Test How Different Doses of BI 1595043 Are Tolerated

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 1595043 in healthy male subjects following oral administration of single rising doses.
Epistemonikos ID: ce08e55727107255dc1a8887bfb1b2667231745f
First added on: May 07, 2024